ZNTL - Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference | Benzinga
NEW YORK and SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that Kimberly Blackwell, M.D., Chief Executive Officer of Zentalis, will participate in a webcast fireside chat at the Oppenheimer Healthcare Life Sciences Conference on Wednesday, February 14, 2024 at 12:40 p.m. ET.
Access to a live webcast of this event, as well as an archived recording, will be available under the ...